All-cause and liver-related mortality in HIV positive subjects compared to the general population: Differences by HCV co-infection

We aimed at comparing overall and liver-related mortality rates, observed in HIV positive subjects followed-up in the Cohorts of Spanish Network on HIV/AIDS Research stratified by HCV co-infection status, with the expected mortality of the general population of same age and sex in Spain, for the per...

Full description

Saved in:
Bibliographic Details
Published inJournal of hepatology Vol. 57; no. 4; pp. 743 - 751
Main Authors Hernando, Victoria, Perez-Cachafeiro, Santiago, Lewden, Charlotte, Gonzalez, Juan, Segura, Ferran, Oteo, Jose Antonio, Rubio, Rafael, Dalmau, David, Moreno, Santiago, Amo, Julia del
Format Journal Article
LanguageEnglish
Published Kidlington Elsevier B.V 01.10.2012
Elsevier
Subjects
HCV
HIV
NSI
MSM
ICD
IQR
HIV
SMR
HCV
IDU
p-y
Online AccessGet full text

Cover

Loading…
Abstract We aimed at comparing overall and liver-related mortality rates, observed in HIV positive subjects followed-up in the Cohorts of Spanish Network on HIV/AIDS Research stratified by HCV co-infection status, with the expected mortality of the general population of same age and sex in Spain, for the period 1997 – 2008. We estimated standardized mortality ratio (SMR) and excess mortality, comparing death rates from our cohort (globally and by HCV co-infection) with death rates from the general population standardized by sex in 5year-age bands. Overall, 5914 HIV positive subjects were included, 37.3% of which were co-infected with HCV; 231 deaths occurred, 10.4% of which were liver-related. SMR for all causes mortality for the HIV positive subjects was 5.6 (CI 95% 4.9–6.4), 2.4 (1.9–3.1) for HCV negative subjects and 11.5 (9.9–13.4) for HCV positive ones. Having HCV co-infection and AIDS yielded an SMR of 20.8 (16.5–26.1) and having AIDS and being HCV negative had an SMR of 4.8 (3.5–6.7). SMR for liver-related mortality was 1.8 (0.6–5.7) for HCV negative subjects vs. 22.4 (14.6–34.3) for HCV positive ones. Overall, both mortality rates as SMR and excess mortality rates were higher for injecting drug users (IDUs) than men having sex with men (MSM) and heterosexuals, patients with AIDS, with and without cART and for subjects included between 1997 and 2003. There was an excess of all-cause and liver-related mortality in our cohorts compared with the general population. Furthermore, HCV co-infection in HIV positive patients increased the risk of death for both all causes and liver-related causes.
AbstractList We aimed at comparing overall and liver-related mortality rates, observed in HIV positive subjects followed-up in the Cohorts of Spanish Network on HIV/AIDS Research stratified by HCV co-infection status, with the expected mortality of the general population of same age and sex in Spain, for the period 1997 – 2008. We estimated standardized mortality ratio (SMR) and excess mortality, comparing death rates from our cohort (globally and by HCV co-infection) with death rates from the general population standardized by sex in 5year-age bands. Overall, 5914 HIV positive subjects were included, 37.3% of which were co-infected with HCV; 231 deaths occurred, 10.4% of which were liver-related. SMR for all causes mortality for the HIV positive subjects was 5.6 (CI 95% 4.9–6.4), 2.4 (1.9–3.1) for HCV negative subjects and 11.5 (9.9–13.4) for HCV positive ones. Having HCV co-infection and AIDS yielded an SMR of 20.8 (16.5–26.1) and having AIDS and being HCV negative had an SMR of 4.8 (3.5–6.7). SMR for liver-related mortality was 1.8 (0.6–5.7) for HCV negative subjects vs. 22.4 (14.6–34.3) for HCV positive ones. Overall, both mortality rates as SMR and excess mortality rates were higher for injecting drug users (IDUs) than men having sex with men (MSM) and heterosexuals, patients with AIDS, with and without cART and for subjects included between 1997 and 2003. There was an excess of all-cause and liver-related mortality in our cohorts compared with the general population. Furthermore, HCV co-infection in HIV positive patients increased the risk of death for both all causes and liver-related causes.
We aimed at comparing overall and liver-related mortality rates, observed in HIV positive subjects followed-up in the Cohorts of Spanish Network on HIV/AIDS Research stratified by HCV co-infection status, with the expected mortality of the general population of same age and sex in Spain, for the period 1997 - 2008. We estimated standardized mortality ratio (SMR) and excess mortality, comparing death rates from our cohort (globally and by HCV co-infection) with death rates from the general population standardized by sex in 5 year-age bands. Overall, 5914 HIV positive subjects were included, 37.3% of which were co-infected with HCV; 231 deaths occurred, 10.4% of which were liver-related. SMR for all causes mortality for the HIV positive subjects was 5.6 (CI 95% 4.9-6.4), 2.4 (1.9-3.1) for HCV negative subjects and 11.5 (9.9-13.4) for HCV positive ones. Having HCV co-infection and AIDS yielded an SMR of 20.8 (16.5-26.1) and having AIDS and being HCV negative had an SMR of 4.8 (3.5-6.7). SMR for liver-related mortality was 1.8 (0.6-5.7) for HCV negative subjects vs. 22.4 (14.6-34.3) for HCV positive ones. Overall, both mortality rates as SMR and excess mortality rates were higher for injecting drug users (IDUs) than men having sex with men (MSM) and heterosexuals, patients with AIDS, with and without cART and for subjects included between 1997 and 2003. There was an excess of all-cause and liver-related mortality in our cohorts compared with the general population. Furthermore, HCV co-infection in HIV positive patients increased the risk of death for both all causes and liver-related causes.
Background & Aims We aimed at comparing overall and liver-related mortality rates, observed in HIV positive subjects followed-up in the Cohorts of Spanish Network on HIV/AIDS Research stratified by HCV co-infection status, with the expected mortality of the general population of same age and sex in Spain, for the period 1997 – 2008. Methods We estimated standardized mortality ratio (SMR) and excess mortality, comparing death rates from our cohort (globally and by HCV co-infection) with death rates from the general population standardized by sex in 5 year-age bands. Results Overall, 5914 HIV positive subjects were included, 37.3% of which were co-infected with HCV; 231 deaths occurred, 10.4% of which were liver-related. SMR for all causes mortality for the HIV positive subjects was 5.6 (CI 95% 4.9–6.4), 2.4 (1.9–3.1) for HCV negative subjects and 11.5 (9.9–13.4) for HCV positive ones. Having HCV co-infection and AIDS yielded an SMR of 20.8 (16.5–26.1) and having AIDS and being HCV negative had an SMR of 4.8 (3.5–6.7). SMR for liver-related mortality was 1.8 (0.6–5.7) for HCV negative subjects vs. 22.4 (14.6–34.3) for HCV positive ones. Overall, both mortality rates as SMR and excess mortality rates were higher for injecting drug users (IDUs) than men having sex with men (MSM) and heterosexuals, patients with AIDS, with and without cART and for subjects included between 1997 and 2003. Conclusions There was an excess of all-cause and liver-related mortality in our cohorts compared with the general population. Furthermore, HCV co-infection in HIV positive patients increased the risk of death for both all causes and liver-related causes.
We aimed at comparing overall and liver-related mortality rates, observed in HIV positive subjects followed-up in the Cohorts of Spanish Network on HIV/AIDS Research stratified by HCV co-infection status, with the expected mortality of the general population of same age and sex in Spain, for the period 1997 - 2008.BACKGROUND & AIMSWe aimed at comparing overall and liver-related mortality rates, observed in HIV positive subjects followed-up in the Cohorts of Spanish Network on HIV/AIDS Research stratified by HCV co-infection status, with the expected mortality of the general population of same age and sex in Spain, for the period 1997 - 2008.We estimated standardized mortality ratio (SMR) and excess mortality, comparing death rates from our cohort (globally and by HCV co-infection) with death rates from the general population standardized by sex in 5 year-age bands.METHODSWe estimated standardized mortality ratio (SMR) and excess mortality, comparing death rates from our cohort (globally and by HCV co-infection) with death rates from the general population standardized by sex in 5 year-age bands.Overall, 5914 HIV positive subjects were included, 37.3% of which were co-infected with HCV; 231 deaths occurred, 10.4% of which were liver-related. SMR for all causes mortality for the HIV positive subjects was 5.6 (CI 95% 4.9-6.4), 2.4 (1.9-3.1) for HCV negative subjects and 11.5 (9.9-13.4) for HCV positive ones. Having HCV co-infection and AIDS yielded an SMR of 20.8 (16.5-26.1) and having AIDS and being HCV negative had an SMR of 4.8 (3.5-6.7). SMR for liver-related mortality was 1.8 (0.6-5.7) for HCV negative subjects vs. 22.4 (14.6-34.3) for HCV positive ones. Overall, both mortality rates as SMR and excess mortality rates were higher for injecting drug users (IDUs) than men having sex with men (MSM) and heterosexuals, patients with AIDS, with and without cART and for subjects included between 1997 and 2003.RESULTSOverall, 5914 HIV positive subjects were included, 37.3% of which were co-infected with HCV; 231 deaths occurred, 10.4% of which were liver-related. SMR for all causes mortality for the HIV positive subjects was 5.6 (CI 95% 4.9-6.4), 2.4 (1.9-3.1) for HCV negative subjects and 11.5 (9.9-13.4) for HCV positive ones. Having HCV co-infection and AIDS yielded an SMR of 20.8 (16.5-26.1) and having AIDS and being HCV negative had an SMR of 4.8 (3.5-6.7). SMR for liver-related mortality was 1.8 (0.6-5.7) for HCV negative subjects vs. 22.4 (14.6-34.3) for HCV positive ones. Overall, both mortality rates as SMR and excess mortality rates were higher for injecting drug users (IDUs) than men having sex with men (MSM) and heterosexuals, patients with AIDS, with and without cART and for subjects included between 1997 and 2003.There was an excess of all-cause and liver-related mortality in our cohorts compared with the general population. Furthermore, HCV co-infection in HIV positive patients increased the risk of death for both all causes and liver-related causes.CONCLUSIONSThere was an excess of all-cause and liver-related mortality in our cohorts compared with the general population. Furthermore, HCV co-infection in HIV positive patients increased the risk of death for both all causes and liver-related causes.
Author Hernando, Victoria
Dalmau, David
Segura, Ferran
Gonzalez, Juan
Lewden, Charlotte
Moreno, Santiago
Perez-Cachafeiro, Santiago
Oteo, Jose Antonio
Rubio, Rafael
Amo, Julia del
Author_xml – sequence: 1
  givenname: Victoria
  surname: Hernando
  fullname: Hernando, Victoria
  email: vhernando@isciii.es
  organization: Red de Investigación en Sida, Centro Nacional de Epidemiología, Instituto de Salud Carlos III, Madrid, Spain
– sequence: 2
  givenname: Santiago
  surname: Perez-Cachafeiro
  fullname: Perez-Cachafeiro, Santiago
  organization: Fundación IDI Complexo Hospitalario de Pontevedra, Pontevedra, Spain
– sequence: 3
  givenname: Charlotte
  surname: Lewden
  fullname: Lewden, Charlotte
  organization: INSERM, U897, Bordeaux, France
– sequence: 4
  givenname: Juan
  surname: Gonzalez
  fullname: Gonzalez, Juan
  organization: Hospital Universitario La Paz, Madrid, Spain
– sequence: 5
  givenname: Ferran
  surname: Segura
  fullname: Segura, Ferran
  organization: Corporació Sanitària Parc Tauli, Sabadell, Spain
– sequence: 6
  givenname: Jose Antonio
  surname: Oteo
  fullname: Oteo, Jose Antonio
  organization: Hospital San Pedro-CIBIR, Logroño, Spain
– sequence: 7
  givenname: Rafael
  surname: Rubio
  fullname: Rubio, Rafael
  organization: Hospital Universitario Doce de Octubre, Madrid, Spain
– sequence: 8
  givenname: David
  surname: Dalmau
  fullname: Dalmau, David
  organization: Hospital Universitarí Mutua de Terrassa, Terrassa, Spain
– sequence: 9
  givenname: Santiago
  surname: Moreno
  fullname: Moreno, Santiago
  organization: Hospital Universitário Ramón y Cajal, Madrid, Spain
– sequence: 10
  givenname: Julia del
  surname: Amo
  fullname: Amo, Julia del
  organization: Red de Investigación en Sida, Centro Nacional de Epidemiología, Instituto de Salud Carlos III, Madrid, Spain
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=26340773$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/22709620$$D View this record in MEDLINE/PubMed
BookMark eNqFkk1v1DAURSNURKeFP8ACeYPEJsOz4zhJhZCq8jGVKrEAurUc55k6eJzUTirNll-Ow0yFVImy8uaca_len2RHfvCYZS8prClQ8bZf9zc4rhlQtgaxBgpPshUVADkITo-yVYLqvGZVfZydxNgDQAENf5YdM1ZBIxissl_nzuVazRGJ8h1x9g5DHtCpCTuyHcKknJ12xHqyubwm4xDtlBAS57ZHPUWih-2oQmKngUw3SH6gx6BcIsc5hdjBn5EP1hgM6DVG0u7I5uI6abn1JiUk4Hn21CgX8cXhPM2-f_r47WKTX335fHlxfpXrshBT3uii7jRAzUttoKJtazquGlFyNEIg413LdKNF1UFZtgVoZrRR2DE0pahqXZxmb_a5YxhuZ4yT3Nqo0TnlcZijpMAp5UVZ8oS-OqBzu8VOjsFuVdjJ-94S8PoAqKiVM0F5beNfThQcqqpIXL3ndBhiDGikttOfWqagrEt3ymVK2ctlSrlMKUHINGVS2QP1Pv1R6d1ewlTkncUgo7ZL850NqW3ZDfZx_f0DXTvrbXrhT9xh7Ic5-DSRpDImR35dPtjyvygD4IVoUsDZvwP-d_tvp0ng-w
CODEN JOHEEC
CitedBy_id crossref_primary_10_1093_cid_ciw846
crossref_primary_10_5501_wjv_v9_i5_54
crossref_primary_10_1111_dar_12425
crossref_primary_10_1097_QAD_0000000000002869
crossref_primary_10_1097_QAD_0000000000003312
crossref_primary_10_1016_S2352_3018_17_30030_9
crossref_primary_10_1097_QAD_0000000000002186
crossref_primary_10_3748_wjg_v25_i4_398
crossref_primary_10_1007_s10461_024_04436_6
crossref_primary_10_1080_19371918_2014_1000506
crossref_primary_10_4103_aam_aam_65_20
crossref_primary_10_1038_nrgastro_2014_17
crossref_primary_10_1371_journal_pone_0103345
crossref_primary_10_1186_s12879_021_06053_3
crossref_primary_10_1016_j_eimc_2015_07_016
crossref_primary_10_1186_s12879_016_1807_5
crossref_primary_10_1097_MD_0000000000010462
crossref_primary_10_1371_journal_pone_0118304
crossref_primary_10_1016_j_ijid_2018_01_021
crossref_primary_10_1097_QAD_0000000000000450
crossref_primary_10_2174_0118746136280350240214064332
crossref_primary_10_1371_journal_pone_0181004
crossref_primary_10_1371_journal_pone_0088623
crossref_primary_10_1093_infdis_jiaa279
crossref_primary_10_1097_QAD_0000000000000222
crossref_primary_10_1111_hiv_12937
crossref_primary_10_1089_apc_2015_0004
crossref_primary_10_1093_ofid_ofw105
crossref_primary_10_1016_j_eimc_2016_02_029
crossref_primary_10_1097_QAI_0000000000000603
crossref_primary_10_7759_cureus_15932
crossref_primary_10_1016_S0140_6736_13_60346_3
crossref_primary_10_1097_COH_0000000000000022
crossref_primary_10_17849_0743_6661_45_1_34
crossref_primary_10_1080_23744235_2021_1898046
crossref_primary_10_1002_cmdc_202000849
crossref_primary_10_1093_ofid_ofac672
crossref_primary_10_1007_s10096_015_2476_9
crossref_primary_10_2139_ssrn_4196958
crossref_primary_10_1111_jvh_12353
crossref_primary_10_1016_j_gtc_2015_07_003
crossref_primary_10_1097_COH_0000000000000306
crossref_primary_10_1111_jvh_12630
crossref_primary_10_1111_hiv_12125
crossref_primary_10_1016_j_dld_2016_06_004
crossref_primary_10_1093_cid_civ438
crossref_primary_10_1080_09540121_2015_1114994
crossref_primary_10_1186_s12876_020_01230_1
crossref_primary_10_1186_s12889_015_1565_0
crossref_primary_10_1007_s11904_015_0277_5
crossref_primary_10_1111_add_12367
crossref_primary_10_1016_j_psychres_2016_09_041
crossref_primary_10_1093_ofid_ofu104
crossref_primary_10_3390_v13102074
crossref_primary_10_1080_09540121_2020_1739209
crossref_primary_10_1093_cid_ciw120
crossref_primary_10_4236_health_2014_614212
crossref_primary_10_1016_j_aohep_2019_05_009
crossref_primary_10_1016_j_jana_2016_10_008
crossref_primary_10_1093_infdis_jis926
crossref_primary_10_1097_COH_0000000000000760
crossref_primary_10_2217_pgs_2018_0046
crossref_primary_10_1111_liv_13544
crossref_primary_10_1080_09540121_2021_1981221
crossref_primary_10_1093_cid_ciw379
crossref_primary_10_1186_s12955_021_01777_x
crossref_primary_10_1186_s13722_015_0041_6
crossref_primary_10_1186_1471_2334_13_382
crossref_primary_10_1097_MD_0000000000016524
crossref_primary_10_1586_17474124_2014_876357
crossref_primary_10_1093_cid_ciu075
crossref_primary_10_1097_QAD_0000000000000377
crossref_primary_10_1007_s11904_014_0217_9
crossref_primary_10_1097_MD_0000000000002127
crossref_primary_10_1007_s11904_013_0182_8
crossref_primary_10_2196_45818
crossref_primary_10_1371_journal_pone_0116226
crossref_primary_10_1177_15248399231169793
crossref_primary_10_1016_S2468_1253_20_30303_4
crossref_primary_10_3748_wjg_v24_i5_613
crossref_primary_10_1089_apc_2015_0040
crossref_primary_10_12968_hmed_2017_78_9_516
crossref_primary_10_1097_QCO_0000000000000125
crossref_primary_10_1038_s41598_025_88530_2
crossref_primary_10_1097_MD_0000000000026507
crossref_primary_10_1016_j_eimce_2016_02_004
crossref_primary_10_1093_cid_cit326
crossref_primary_10_3851_IMP2960
crossref_primary_10_1097_COH_0000000000000183
crossref_primary_10_47102_annals_acadmedsg_V41N12p571
crossref_primary_10_1016_j_clinre_2015_04_001
crossref_primary_10_1016_j_med_2022_05_021
crossref_primary_10_1038_s41598_020_80311_3
crossref_primary_10_3390_cells10051212
crossref_primary_10_1097_MD_0000000000004727
crossref_primary_10_1097_QAD_0000000000002054
crossref_primary_10_1186_s12967_014_0341_8
Cites_doi 10.1002/hep.23020
10.1016/j.jhep.2005.11.034
10.1086/520092
10.1157/13096749
10.1097/QAI.0b013e318134257a
10.1097/01.aids.0000163936.99401.fe
10.1097/01.qai.0000194232.85336.dc
10.3851/IMP1939
10.1016/S0140-6736(10)60932-4
10.1093/ije/dyp306
10.1086/652283
10.1093/ije/dyh307
10.1097/01.qai.0000233310.90484.16
10.1086/598333
10.1086/432762
10.1016/j.eimc.2011.06.002
10.1097/QAI.0b013e31817efb54
10.1111/j.1365-2559.2005.02243.x
10.1111/j.1440-1746.2008.05489.x
10.1097/QAI.0b013e3181acb4e5
10.1097/QAD.0b013e3283324283
10.1016/j.gaceta.2008.05.003
10.7326/0003-4819-138-3-200302040-00012
10.1111/j.1468-1293.2005.00271.x
10.1186/1471-2458-11-300
10.1097/01.aids.0000216375.99560.a2
10.1097/QAD.0b013e328352ada4
10.1097/QAD.0b013e32830e6d51
10.1111/j.1365-2893.2007.00903.x
10.1001/jama.300.1.51
10.1097/01.aids.0000192065.09281.01
10.1086/644771
10.1016/j.cld.2005.05.003
ContentType Journal Article
Copyright 2012 European Association for the Study of the Liver
European Association for the Study of the Liver
2015 INIST-CNRS
Copyright © 2012 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
Copyright_xml – notice: 2012 European Association for the Study of the Liver
– notice: European Association for the Study of the Liver
– notice: 2015 INIST-CNRS
– notice: Copyright © 2012 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
CorporateAuthor CoRIS
CorporateAuthor_xml – name: CoRIS
DBID AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1016/j.jhep.2012.06.010
DatabaseName CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList
MEDLINE

MEDLINE - Academic

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1600-0641
EndPage 751
ExternalDocumentID 22709620
26340773
10_1016_j_jhep_2012_06_010
S0168827812004369
1_s2_0_S0168827812004369
Genre Research Support, Non-U.S. Gov't
Journal Article
GeographicLocations Spain
GeographicLocations_xml – name: Spain
GroupedDBID ---
--K
--M
.1-
.55
.FO
.GJ
.~1
0R~
1B1
1P~
1RT
1~.
1~5
29K
3O-
4.4
457
4G.
53G
5GY
5RE
5VS
7-5
71M
8P~
9JM
AABNK
AAEDT
AAEDW
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQQT
AAQXK
AATTM
AAXKI
AAXUO
AAYWO
ABBQC
ABFNM
ABFRF
ABJNI
ABMAC
ABMZM
ABWVN
ABXDB
ACDAQ
ACGFO
ACGFS
ACIEU
ACIUM
ACRLP
ACRPL
ACVFH
ADBBV
ADCNI
ADEZE
ADMUD
ADNMO
ADVLN
AEBSH
AEFWE
AEIPS
AEKER
AENEX
AEUPX
AEVXI
AFFNX
AFJKZ
AFPUW
AFRHN
AFTJW
AFXIZ
AGCQF
AGHFR
AGQPQ
AGUBO
AGYEJ
AHHHB
AIEXJ
AIGII
AIIUN
AIKHN
AITUG
AJRQY
AJUYK
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ANKPU
ANZVX
APXCP
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
BNPGV
CS3
D-I
DU5
EBS
EFJIC
EFKBS
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-2
G-Q
GBLVA
HDZ
HMK
HMO
HVGLF
HX~
HZ~
IHE
J1W
KOM
LZ1
M27
M41
MJL
MO0
N9A
O-L
O9-
OAUVE
OC.
ON0
OVD
OZT
P-8
P-9
P2P
PC.
Q38
R2-
ROL
RPZ
SAE
SCC
SDF
SDG
SDP
SEL
SES
SEW
SPCBC
SSH
SSZ
T5K
TEORI
UV1
WUQ
X7M
YOC
Z5R
ZGI
~G-
AACTN
AFCTW
AFKWA
AJOXV
AMFUW
RIG
AAIAV
ABLVK
ABYKQ
AHPSJ
AJBFU
EFLBG
LCYCR
AAYXX
AGRNS
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ID FETCH-LOGICAL-c536t-9c38dc00845cf071bbfd4a9654ef66e24db2c9c67d055b30c2fcfaed2ef5678c3
IEDL.DBID .~1
ISSN 0168-8278
1600-0641
IngestDate Thu Aug 07 15:22:50 EDT 2025
Mon Jul 21 05:51:08 EDT 2025
Mon Jul 21 09:14:41 EDT 2025
Tue Jul 01 02:21:27 EDT 2025
Thu Apr 24 23:05:41 EDT 2025
Fri Feb 23 02:27:18 EST 2024
Sun Feb 23 10:19:32 EST 2025
Tue Aug 26 20:13:18 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 4
Keywords Standardized mortality ratio
NSI
MSM
Mortality
HIV VL
AIDS
ICD
IQR
cART
Cause of death
CoRIS-MD
NBDF
CoRIS
HIV
SMR
HCV
IDU
p-y
Human Immunodeficiency Virus
Retrospective Cohort of Spanish Network on HIV/AIDS Research (in Spanish Cohorte de la Red de Investigación en SIDA)
persons-year
National Statistics Institute
injecting drug user
Acquired Immunodeficiency Syndrome
Interquartile rate
combined antiretroviral treatment
Prospective Cohort of Spanish Network on HIV/AIDS Research (in Spanish Cohorte de la Red de Investigación en SIDA)
Hepatitis C Virus
International Classification of Diseases
standardized mortality ratio
men having sex with men
National Basic Death File
HIV viral load
Human
Immunopathology
Mixed infection
Prognosis
Liver
Retroviridae
Hepatic disease
Immune deficiency
Lentivirus
Epidemiology
Infection
Virus
Viral disease
Gastroenterology
Digestive diseases
Human immunodeficiency virus
Viral hepatitis C
Language English
License https://www.elsevier.com/tdm/userlicense/1.0
CC BY 4.0
Copyright © 2012 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c536t-9c38dc00845cf071bbfd4a9654ef66e24db2c9c67d055b30c2fcfaed2ef5678c3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink http://hdl.handle.net/20.500.11940/7391
PMID 22709620
PQID 1041143554
PQPubID 23479
PageCount 9
ParticipantIDs proquest_miscellaneous_1041143554
pubmed_primary_22709620
pascalfrancis_primary_26340773
crossref_citationtrail_10_1016_j_jhep_2012_06_010
crossref_primary_10_1016_j_jhep_2012_06_010
elsevier_sciencedirect_doi_10_1016_j_jhep_2012_06_010
elsevier_clinicalkeyesjournals_1_s2_0_S0168827812004369
elsevier_clinicalkey_doi_10_1016_j_jhep_2012_06_010
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2012-10-01
PublicationDateYYYYMMDD 2012-10-01
PublicationDate_xml – month: 10
  year: 2012
  text: 2012-10-01
  day: 01
PublicationDecade 2010
PublicationPlace Kidlington
PublicationPlace_xml – name: Kidlington
– name: Netherlands
PublicationTitle Journal of hepatology
PublicationTitleAlternate J Hepatol
PublicationYear 2012
Publisher Elsevier B.V
Elsevier
Publisher_xml – name: Elsevier B.V
– name: Elsevier
References Rockstroh, Mocroft, Soriano, Tural, Losso, Horban (b0085) 2005; 192
Backus, Boothroyd, Deyton (b0130) 2005; 19
Lewden, May, Rosenthal, Burty, Bonnet, Costagliola (b0135) 2008; 48
Sulkowski, Thomas (b0070) 2003; 138
Thein, Yi, Dore, Krahn (b0075) 2008; 22
Roulson, Benbow, Hasleton (b0210) 2005; 47
Aldaz, Moreno-Iribas, Egues, Irisarri, Floristan, Sola-Boneta (b0015) 2011; 11
Encuesta Nacional de Salud, año 2006. Instituto Nacional de Estadistica.
Perez, del Amo, Iribarren, Salavert, Gutierrez, Moreno (b0100) 2009; 48
Berenguer J, Alejos-Ferreras B, Hernando V, Viciana P, Oteo JA, Gomez-Sirvent JL, et al. Temporal trends in liver-related mortality in a prospective cohort of HIV-infected patients in Spain, 1977–2008, 6th IAS Conference on HIV Pathogenesis, Treatment and Prevention, Rome (Italy), July 2011 ed 2011.
Hernando V, Sobrino-Vegas P, Burriel MC, Berenguer J, Navarro G, Santos I, et al. Differences in the causes of death of HIV positive subjects in a cohort study by data sources and coding algorithms. AIDS 2012, in press. [Epub ahead of print].
Salmon, Robain, Rockstroh, Benhamou (b0195) 2006; 44
Thomas, Seeff (b0205) 2005; 9
Gonzalez-Garcia, Mahillo, Hernandez, Pacheco, Diz, Garcia (b0105) 2005; 23
Krentz, Kliewer, Gill (b0005) 2005; 6
French, Gawel, Hershow, Benning, Hessol, Levine (b0025) 2009; 51
Sobrino-Vegas, Rodriguez-Urrego, Berenguer, Caro-Murillo, Blanco, Viciana (b0180) 2012; 17
Castellares, Barreiro, Martin-Carbonero, Labarga, Vispo, Casado (b0155) 2008; 15
Palella, Baker, Moorman, Chmiel, Wood, Brooks (b0010) 2006; 43
Lewden, Chene, Morlat, Raffi, Dupon, Dellamonica (b0030) 2007; 46
Zwahlen, Harris, May, Hogg, Costagliola, de Wolf (b0020) 2009; 38
Labarga, Soriano, Vispo, Pinilla, Martin-Carbonero, Castellares (b0200) 2007; 196
Lumbreras, Jarrin, del Amo, Perez-Hoyos, Muga, Garcia-de la Hera (b0095) 1990; 2006
Berenguer, Alvarez-Pellicer, Martin, Lopez-Aldeguer, Von Wichmann, Quereda (b0190) 2009; 50
Masia M, Perez-Cachafeiro S, Leyes M, López-Aldeguer J, López M, Segura F, et al., in press. Cardiovascular risk in HIV positive patients in Spain. CoRIS cohort, 2011. Enferm Infecc Microbiol Clin 2012
Bhaskaran, Hamouda, Sannes, Boufassa, Johnson, Lambert (b0040) 2008; 300
Sobrino-Vegas, Gutierrez, Berenguer, Labarga, Garcia, Alejos-Ferreras (b0125) 2011; 29
Ruppik M, Ledergerber B, Rickenbach M, Furrer H, Battegay M, Cavassini M, et al. Changing patterns of causes of death in the Swiss HIV Cohort Study (SHCS) 2005–2009. In: 18th conference on retroviruses and opportunistic infections; 2011.
Konopnicki, Mocroft, de Wit, Antunes, Ledergerber, Katlama (b0055) 2005; 19
Pulido, Brugal, De la, Ballesta, Barrio, Bravo (b0150) 2009; 23
Rodriguez-Arenas MA, Gutierrez-Trujillo L, Robledano C, Rodríguez-Fortunez P, del Romero J, Rodriguez-Fernandez JM, et al. Prevalencia de consumo de drogas y adherencia a TARc, por sexo, en la cohorte hospitalario CoRIS de personas con infección por VIH., XIV Congreso Nacional sobre el SIDA, June. Zaragoza (Spain) ed 2011.
Matthews, Dore (b0140) 2008; 23
Ray, Logan, Sterne, Hernadez-Diaz, Robins, Sabin (b0185) 2010; 24
Lodwick, Sabin, Porter, Ledergerber, van Sighem, Cozzi-Lepri (b0035) 2010; 376
.
Smit, Geskus, Walker, Sabin, Coutinho, Porter (b0065) 2006; 20
The Antiretroviral Therapy Cohort Collaboration. Causes of death in HIV-1-infected patients treated with antiretroviral therapy, 1996–2006: collaborative analysis of 13 HIV cohort studies. Clin Infect Dis 2010;50:1387–1396.
Caro-Murillo, Castilla, Perez-Hoyos, Miro, Podzamczer, Rubio (b0120) 2007; 25
Ministry of Health SPaE. Patterns of mortality in Spain, 2008. 2011. Report No.
Lewden, Salmon, Morlat, Bevilacqua, Jougla, Bonnet (b0060) 2005; 34
Sulkowski MS, Mehta SH, Montes de Oca R, Moore RD, Thomas DL. Estimated prevalence of significant liver disease among 4.052 HIV-infected adults with and without chronic viral hepatitis. In: 13th conference on retroviruses and opportunistic infections; 2006.
Chen, Ding, Seage Iii, Kim (b0080) 2009; 49
del Amo, Perez-Hoyos, Moreno, Quintana, Ruiz, Cisneros (b0090) 2006; 41
French (10.1016/j.jhep.2012.06.010_b0025) 2009; 51
10.1016/j.jhep.2012.06.010_b0145
10.1016/j.jhep.2012.06.010_b0165
Lewden (10.1016/j.jhep.2012.06.010_b0030) 2007; 46
10.1016/j.jhep.2012.06.010_b0045
Perez (10.1016/j.jhep.2012.06.010_b0100) 2009; 48
Zwahlen (10.1016/j.jhep.2012.06.010_b0020) 2009; 38
10.1016/j.jhep.2012.06.010_b0160
Salmon (10.1016/j.jhep.2012.06.010_b0195) 2006; 44
Sulkowski (10.1016/j.jhep.2012.06.010_b0070) 2003; 138
Aldaz (10.1016/j.jhep.2012.06.010_b0015) 2011; 11
Castellares (10.1016/j.jhep.2012.06.010_b0155) 2008; 15
Bhaskaran (10.1016/j.jhep.2012.06.010_b0040) 2008; 300
Lewden (10.1016/j.jhep.2012.06.010_b0135) 2008; 48
Roulson (10.1016/j.jhep.2012.06.010_b0210) 2005; 47
Sobrino-Vegas (10.1016/j.jhep.2012.06.010_b0180) 2012; 17
Ray (10.1016/j.jhep.2012.06.010_b0185) 2010; 24
Lodwick (10.1016/j.jhep.2012.06.010_b0035) 2010; 376
Chen (10.1016/j.jhep.2012.06.010_b0080) 2009; 49
10.1016/j.jhep.2012.06.010_b0115
Thomas (10.1016/j.jhep.2012.06.010_b0205) 2005; 9
Lumbreras (10.1016/j.jhep.2012.06.010_b0095) 1990; 2006
Rockstroh (10.1016/j.jhep.2012.06.010_b0085) 2005; 192
Gonzalez-Garcia (10.1016/j.jhep.2012.06.010_b0105) 2005; 23
10.1016/j.jhep.2012.06.010_b0110
del Amo (10.1016/j.jhep.2012.06.010_b0090) 2006; 41
10.1016/j.jhep.2012.06.010_b0175
Konopnicki (10.1016/j.jhep.2012.06.010_b0055) 2005; 19
10.1016/j.jhep.2012.06.010_b0170
10.1016/j.jhep.2012.06.010_b0050
Matthews (10.1016/j.jhep.2012.06.010_b0140) 2008; 23
Palella (10.1016/j.jhep.2012.06.010_b0010) 2006; 43
Sobrino-Vegas (10.1016/j.jhep.2012.06.010_b0125) 2011; 29
Labarga (10.1016/j.jhep.2012.06.010_b0200) 2007; 196
Pulido (10.1016/j.jhep.2012.06.010_b0150) 2009; 23
Berenguer (10.1016/j.jhep.2012.06.010_b0190) 2009; 50
Thein (10.1016/j.jhep.2012.06.010_b0075) 2008; 22
Smit (10.1016/j.jhep.2012.06.010_b0065) 2006; 20
Caro-Murillo (10.1016/j.jhep.2012.06.010_b0120) 2007; 25
Backus (10.1016/j.jhep.2012.06.010_b0130) 2005; 19
Krentz (10.1016/j.jhep.2012.06.010_b0005) 2005; 6
Lewden (10.1016/j.jhep.2012.06.010_b0060) 2005; 34
References_xml – volume: 15
  start-page: 165
  year: 2008
  end-page: 172
  ident: b0155
  article-title: Liver cirrhosis in HIV-infected patients: prevalence, aetiology and clinical outcome
  publication-title: J Viral Hepat
– reference: Masia M, Perez-Cachafeiro S, Leyes M, López-Aldeguer J, López M, Segura F, et al., in press. Cardiovascular risk in HIV positive patients in Spain. CoRIS cohort, 2011. Enferm Infecc Microbiol Clin 2012
– volume: 24
  start-page: 123
  year: 2010
  end-page: 137
  ident: b0185
  article-title: The effect of combined antiretroviral therapy on the overall mortality of HIV-infected individuals
  publication-title: AIDS
– volume: 23
  start-page: 1000
  year: 2008
  end-page: 1008
  ident: b0140
  article-title: HIV and hepatitis C coinfection
  publication-title: J Gastroenterol Hepatol
– volume: 19
  start-page: 593
  year: 2005
  end-page: 601
  ident: b0055
  article-title: Hepatitis B and HIV: prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort
  publication-title: AIDS
– volume: 23
  start-page: 200
  year: 2009
  end-page: 207
  ident: b0150
  article-title: Recruitment methodology and characteristics of a cohort of young regular cocaine users in three Spanish cities (the Itinere-cocaine Project)
  publication-title: Gac Sanit
– volume: 25
  start-page: 23
  year: 2007
  end-page: 31
  ident: b0120
  article-title: Spanish cohort of naive HIV-infected patients (CoRIS): rationale, organization and initial results
  publication-title: Enferm Infecc Microbiol Clin
– volume: 376
  start-page: 340
  year: 2010
  end-page: 345
  ident: b0035
  article-title: Death rates in HIV positive antiretroviral-naive patients with CD4 count greater than 350 cells per microL in Europe and North America: a pooled cohort observational study
  publication-title: Lancet
– volume: 49
  start-page: 1605
  year: 2009
  end-page: 1615
  ident: b0080
  article-title: Meta-analysis: increased mortality associated with hepatitis C in HIV-infected persons is unrelated to HIV disease progression
  publication-title: Clin Infect Dis
– volume: 192
  start-page: 992
  year: 2005
  end-page: 1002
  ident: b0085
  article-title: Influence of hepatitis C virus infection on HIV-1 disease progression and response to highly active antiretroviral therapy
  publication-title: J Infect Dis
– volume: 44
  start-page: S2
  year: 2006
  end-page: S5
  ident: b0195
  article-title: Therapeutic management of hepatitis and HIV infection in co-infected patients: results of a survey performed before the 2005 Consensus Conference
  publication-title: J Hepatol
– volume: 9
  start-page: 383
  year: 2005
  end-page: 398
  ident: b0205
  article-title: Natural history of hepatitis C
  publication-title: Clin Liver Dis
– volume: 23
  start-page: 340
  year: 2005
  end-page: 348
  ident: b0105
  article-title: Prevalences of hepatitis virus coinfection and indications for chronic hepatitis C virus treatment and liver transplantation in Spanish HIV-infected patients. The GESIDA 29/02 and FIPSE 12185/01 Multicenter Study
  publication-title: Enferm Infecc Microbiol Clin
– reference: Hernando V, Sobrino-Vegas P, Burriel MC, Berenguer J, Navarro G, Santos I, et al. Differences in the causes of death of HIV positive subjects in a cohort study by data sources and coding algorithms. AIDS 2012, in press. [Epub ahead of print].
– volume: 19
  start-page: S13
  year: 2005
  end-page: S19
  ident: b0130
  article-title: HIV, hepatitis C and HIV/hepatitis C virus co-infection in vulnerable populations
  publication-title: AIDS
– volume: 48
  start-page: 590
  year: 2008
  end-page: 598
  ident: b0135
  article-title: Changes in causes of death among adults infected by HIV between 2000 and 2005: The “Mortalite 2000 and 2005” surveys (ANRS EN19 and Mortavic)
  publication-title: J Acquir Immune Defic Syndr
– volume: 17
  start-page: 1
  year: 2012
  end-page: 8
  ident: b0180
  article-title: Educational gradient in HIV diagnosis delay, mortality, antiretroviral treatment initiation and response in a country with universal health care
  publication-title: Antivir Ther
– volume: 43
  start-page: 27
  year: 2006
  end-page: 34
  ident: b0010
  article-title: Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study
  publication-title: J Acquir Immune Defic Syndr
– reference: Ruppik M, Ledergerber B, Rickenbach M, Furrer H, Battegay M, Cavassini M, et al. Changing patterns of causes of death in the Swiss HIV Cohort Study (SHCS) 2005–2009. In: 18th conference on retroviruses and opportunistic infections; 2011.
– volume: 41
  start-page: 624
  year: 2006
  end-page: 631
  ident: b0090
  article-title: Trends in AIDS and mortality in HIV-infected subjects with hemophilia from 1985 to 2003: the competing risks for death between AIDS and liver disease
  publication-title: J Acquir Immune Defic Syndr
– volume: 11
  start-page: 300
  year: 2011
  ident: b0015
  article-title: Mortality by causes in HIV-infected adults: comparison with the general population
  publication-title: BMC Pub Health
– volume: 22
  start-page: 1979
  year: 2008
  end-page: 1991
  ident: b0075
  article-title: Natural history of hepatitis C virus infection in HIV-infected individuals and the impact of HIV in the era of highly active antiretroviral therapy: a meta-analysis
  publication-title: AIDS
– reference: Encuesta Nacional de Salud, año 2006. Instituto Nacional de Estadistica.
– volume: 2006
  start-page: 111
  year: 1990
  end-page: 116
  ident: b0095
  article-title: Impact of hepatitis C infection on long-term mortality of injecting drug users from 1990 to 2002: differences before and after HAART
  publication-title: AIDS
– volume: 47
  start-page: 551
  year: 2005
  end-page: 559
  ident: b0210
  article-title: Discrepancies between clinical and autopsy diagnosis and the value of post mortem histology; a meta-analysis and review
  publication-title: Histopathology
– reference: Ministry of Health SPaE. Patterns of mortality in Spain, 2008. 2011. Report No.:
– volume: 48
  start-page: 1467
  year: 2009
  end-page: 1470
  ident: b0100
  article-title: Decrease in serial prevalence of coinfection with hepatitis C virus among HIV-infected patients in Spain, 1997–2006
  publication-title: Clin Infect Dis
– volume: 20
  start-page: 741
  year: 2006
  end-page: 749
  ident: b0065
  article-title: Effective therapy has altered the spectrum of cause-specific mortality following HIV seroconversion
  publication-title: AIDS
– reference: Berenguer J, Alejos-Ferreras B, Hernando V, Viciana P, Oteo JA, Gomez-Sirvent JL, et al. Temporal trends in liver-related mortality in a prospective cohort of HIV-infected patients in Spain, 1977–2008, 6th IAS Conference on HIV Pathogenesis, Treatment and Prevention, Rome (Italy), July 2011 ed 2011.
– volume: 46
  start-page: 72
  year: 2007
  end-page: 77
  ident: b0030
  article-title: HIV-infected adults with a CD4 cell count greater than 500 cells/mm3 on long-term combination antiretroviral therapy reach same mortality rates as the general population
  publication-title: J Acquir Immune Defic Syndr
– reference: .
– volume: 6
  start-page: 99
  year: 2005
  end-page: 106
  ident: b0005
  article-title: Changing mortality rates and causes of death for HIV-infected individuals living in Southern Alberta, Canada from 1984 to 2003
  publication-title: HIV Med
– volume: 300
  start-page: 51
  year: 2008
  end-page: 59
  ident: b0040
  article-title: Changes in the risk of death after HIV seroconversion compared with mortality in the general population
  publication-title: JAMA
– volume: 34
  start-page: 121
  year: 2005
  end-page: 130
  ident: b0060
  article-title: Causes of death among human immunodeficiency virus (HIV)-infected adults in the era of potent antiretroviral therapy: emerging role of hepatitis and cancers, persistent role of AIDS
  publication-title: Int J Epidemiol
– volume: 138
  start-page: 197
  year: 2003
  end-page: 207
  ident: b0070
  article-title: Hepatitis C in the HIV-infected person
  publication-title: Ann Intern Med
– volume: 38
  start-page: 1624
  year: 2009
  end-page: 1633
  ident: b0020
  article-title: Mortality of HIV-infected patients starting potent antiretroviral therapy: comparison with the general population in nine industrialized countries
  publication-title: Int J Epidemiol
– volume: 51
  start-page: 399
  year: 2009
  end-page: 406
  ident: b0025
  article-title: Trends in mortality and causes of death among women with HIV in the United States: a 10-year study
  publication-title: J Acquir Immune Defic Syndr
– volume: 196
  start-page: 670
  year: 2007
  end-page: 676
  ident: b0200
  article-title: Hepatotoxicity of antiretroviral drugs is reduced after successful treatment of chronic hepatitis C in HIV-infected patients
  publication-title: J Infect Dis
– volume: 50
  start-page: 407
  year: 2009
  end-page: 413
  ident: b0190
  article-title: Sustained virological response to interferon plus ribavirin reduces liver-related complications and mortality in patients coinfected with human immunodeficiency virus and hepatitis C virus
  publication-title: Hepatology
– reference: The Antiretroviral Therapy Cohort Collaboration. Causes of death in HIV-1-infected patients treated with antiretroviral therapy, 1996–2006: collaborative analysis of 13 HIV cohort studies. Clin Infect Dis 2010;50:1387–1396.
– volume: 29
  start-page: 645
  year: 2011
  end-page: 653
  ident: b0125
  article-title: The cohort of the spanish hiv research network (coris) and its associated biobank; organizational issues, main findings and losses to follow-up
  publication-title: Enferm Infecc Microbiol Clin
– reference: Sulkowski MS, Mehta SH, Montes de Oca R, Moore RD, Thomas DL. Estimated prevalence of significant liver disease among 4.052 HIV-infected adults with and without chronic viral hepatitis. In: 13th conference on retroviruses and opportunistic infections; 2006.
– reference: Rodriguez-Arenas MA, Gutierrez-Trujillo L, Robledano C, Rodríguez-Fortunez P, del Romero J, Rodriguez-Fernandez JM, et al. Prevalencia de consumo de drogas y adherencia a TARc, por sexo, en la cohorte hospitalario CoRIS de personas con infección por VIH., XIV Congreso Nacional sobre el SIDA, June. Zaragoza (Spain) ed 2011.
– volume: 23
  start-page: 340
  year: 2005
  ident: 10.1016/j.jhep.2012.06.010_b0105
  article-title: Prevalences of hepatitis virus coinfection and indications for chronic hepatitis C virus treatment and liver transplantation in Spanish HIV-infected patients. The GESIDA 29/02 and FIPSE 12185/01 Multicenter Study
  publication-title: Enferm Infecc Microbiol Clin
– volume: 50
  start-page: 407
  year: 2009
  ident: 10.1016/j.jhep.2012.06.010_b0190
  article-title: Sustained virological response to interferon plus ribavirin reduces liver-related complications and mortality in patients coinfected with human immunodeficiency virus and hepatitis C virus
  publication-title: Hepatology
  doi: 10.1002/hep.23020
– volume: 44
  start-page: S2
  year: 2006
  ident: 10.1016/j.jhep.2012.06.010_b0195
  article-title: Therapeutic management of hepatitis and HIV infection in co-infected patients: results of a survey performed before the 2005 Consensus Conference
  publication-title: J Hepatol
  doi: 10.1016/j.jhep.2005.11.034
– volume: 196
  start-page: 670
  year: 2007
  ident: 10.1016/j.jhep.2012.06.010_b0200
  article-title: Hepatotoxicity of antiretroviral drugs is reduced after successful treatment of chronic hepatitis C in HIV-infected patients
  publication-title: J Infect Dis
  doi: 10.1086/520092
– volume: 25
  start-page: 23
  year: 2007
  ident: 10.1016/j.jhep.2012.06.010_b0120
  article-title: Spanish cohort of naive HIV-infected patients (CoRIS): rationale, organization and initial results
  publication-title: Enferm Infecc Microbiol Clin
  doi: 10.1157/13096749
– volume: 46
  start-page: 72
  year: 2007
  ident: 10.1016/j.jhep.2012.06.010_b0030
  article-title: HIV-infected adults with a CD4 cell count greater than 500 cells/mm3 on long-term combination antiretroviral therapy reach same mortality rates as the general population
  publication-title: J Acquir Immune Defic Syndr
  doi: 10.1097/QAI.0b013e318134257a
– volume: 19
  start-page: 593
  year: 2005
  ident: 10.1016/j.jhep.2012.06.010_b0055
  article-title: Hepatitis B and HIV: prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort
  publication-title: AIDS
  doi: 10.1097/01.aids.0000163936.99401.fe
– ident: 10.1016/j.jhep.2012.06.010_b0165
– volume: 41
  start-page: 624
  year: 2006
  ident: 10.1016/j.jhep.2012.06.010_b0090
  article-title: Trends in AIDS and mortality in HIV-infected subjects with hemophilia from 1985 to 2003: the competing risks for death between AIDS and liver disease
  publication-title: J Acquir Immune Defic Syndr
  doi: 10.1097/01.qai.0000194232.85336.dc
– ident: 10.1016/j.jhep.2012.06.010_b0050
– volume: 2006
  start-page: 111
  year: 1990
  ident: 10.1016/j.jhep.2012.06.010_b0095
  article-title: Impact of hepatitis C infection on long-term mortality of injecting drug users from 1990 to 2002: differences before and after HAART
  publication-title: AIDS
– volume: 17
  start-page: 1
  year: 2012
  ident: 10.1016/j.jhep.2012.06.010_b0180
  article-title: Educational gradient in HIV diagnosis delay, mortality, antiretroviral treatment initiation and response in a country with universal health care
  publication-title: Antivir Ther
  doi: 10.3851/IMP1939
– volume: 376
  start-page: 340
  year: 2010
  ident: 10.1016/j.jhep.2012.06.010_b0035
  article-title: Death rates in HIV positive antiretroviral-naive patients with CD4 count greater than 350 cells per microL in Europe and North America: a pooled cohort observational study
  publication-title: Lancet
  doi: 10.1016/S0140-6736(10)60932-4
– volume: 38
  start-page: 1624
  year: 2009
  ident: 10.1016/j.jhep.2012.06.010_b0020
  article-title: Mortality of HIV-infected patients starting potent antiretroviral therapy: comparison with the general population in nine industrialized countries
  publication-title: Int J Epidemiol
  doi: 10.1093/ije/dyp306
– ident: 10.1016/j.jhep.2012.06.010_b0045
  doi: 10.1086/652283
– volume: 34
  start-page: 121
  year: 2005
  ident: 10.1016/j.jhep.2012.06.010_b0060
  article-title: Causes of death among human immunodeficiency virus (HIV)-infected adults in the era of potent antiretroviral therapy: emerging role of hepatitis and cancers, persistent role of AIDS
  publication-title: Int J Epidemiol
  doi: 10.1093/ije/dyh307
– volume: 43
  start-page: 27
  year: 2006
  ident: 10.1016/j.jhep.2012.06.010_b0010
  article-title: Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study
  publication-title: J Acquir Immune Defic Syndr
  doi: 10.1097/01.qai.0000233310.90484.16
– volume: 48
  start-page: 1467
  year: 2009
  ident: 10.1016/j.jhep.2012.06.010_b0100
  article-title: Decrease in serial prevalence of coinfection with hepatitis C virus among HIV-infected patients in Spain, 1997–2006
  publication-title: Clin Infect Dis
  doi: 10.1086/598333
– volume: 192
  start-page: 992
  year: 2005
  ident: 10.1016/j.jhep.2012.06.010_b0085
  article-title: Influence of hepatitis C virus infection on HIV-1 disease progression and response to highly active antiretroviral therapy
  publication-title: J Infect Dis
  doi: 10.1086/432762
– volume: 29
  start-page: 645
  year: 2011
  ident: 10.1016/j.jhep.2012.06.010_b0125
  article-title: The cohort of the spanish hiv research network (coris) and its associated biobank; organizational issues, main findings and losses to follow-up
  publication-title: Enferm Infecc Microbiol Clin
  doi: 10.1016/j.eimc.2011.06.002
– volume: 48
  start-page: 590
  year: 2008
  ident: 10.1016/j.jhep.2012.06.010_b0135
  article-title: Changes in causes of death among adults infected by HIV between 2000 and 2005: The “Mortalite 2000 and 2005” surveys (ANRS EN19 and Mortavic)
  publication-title: J Acquir Immune Defic Syndr
  doi: 10.1097/QAI.0b013e31817efb54
– ident: 10.1016/j.jhep.2012.06.010_b0170
– volume: 47
  start-page: 551
  year: 2005
  ident: 10.1016/j.jhep.2012.06.010_b0210
  article-title: Discrepancies between clinical and autopsy diagnosis and the value of post mortem histology; a meta-analysis and review
  publication-title: Histopathology
  doi: 10.1111/j.1365-2559.2005.02243.x
– volume: 23
  start-page: 1000
  year: 2008
  ident: 10.1016/j.jhep.2012.06.010_b0140
  article-title: HIV and hepatitis C coinfection
  publication-title: J Gastroenterol Hepatol
  doi: 10.1111/j.1440-1746.2008.05489.x
– volume: 51
  start-page: 399
  year: 2009
  ident: 10.1016/j.jhep.2012.06.010_b0025
  article-title: Trends in mortality and causes of death among women with HIV in the United States: a 10-year study
  publication-title: J Acquir Immune Defic Syndr
  doi: 10.1097/QAI.0b013e3181acb4e5
– volume: 24
  start-page: 123
  year: 2010
  ident: 10.1016/j.jhep.2012.06.010_b0185
  article-title: The effect of combined antiretroviral therapy on the overall mortality of HIV-infected individuals
  publication-title: AIDS
  doi: 10.1097/QAD.0b013e3283324283
– volume: 23
  start-page: 200
  year: 2009
  ident: 10.1016/j.jhep.2012.06.010_b0150
  article-title: Recruitment methodology and characteristics of a cohort of young regular cocaine users in three Spanish cities (the Itinere-cocaine Project)
  publication-title: Gac Sanit
  doi: 10.1016/j.gaceta.2008.05.003
– ident: 10.1016/j.jhep.2012.06.010_b0160
– volume: 138
  start-page: 197
  year: 2003
  ident: 10.1016/j.jhep.2012.06.010_b0070
  article-title: Hepatitis C in the HIV-infected person
  publication-title: Ann Intern Med
  doi: 10.7326/0003-4819-138-3-200302040-00012
– ident: 10.1016/j.jhep.2012.06.010_b0145
– volume: 6
  start-page: 99
  year: 2005
  ident: 10.1016/j.jhep.2012.06.010_b0005
  article-title: Changing mortality rates and causes of death for HIV-infected individuals living in Southern Alberta, Canada from 1984 to 2003
  publication-title: HIV Med
  doi: 10.1111/j.1468-1293.2005.00271.x
– volume: 11
  start-page: 300
  year: 2011
  ident: 10.1016/j.jhep.2012.06.010_b0015
  article-title: Mortality by causes in HIV-infected adults: comparison with the general population
  publication-title: BMC Pub Health
  doi: 10.1186/1471-2458-11-300
– volume: 20
  start-page: 741
  year: 2006
  ident: 10.1016/j.jhep.2012.06.010_b0065
  article-title: Effective therapy has altered the spectrum of cause-specific mortality following HIV seroconversion
  publication-title: AIDS
  doi: 10.1097/01.aids.0000216375.99560.a2
– ident: 10.1016/j.jhep.2012.06.010_b0110
– ident: 10.1016/j.jhep.2012.06.010_b0115
  doi: 10.1097/QAD.0b013e328352ada4
– ident: 10.1016/j.jhep.2012.06.010_b0175
– volume: 22
  start-page: 1979
  year: 2008
  ident: 10.1016/j.jhep.2012.06.010_b0075
  article-title: Natural history of hepatitis C virus infection in HIV-infected individuals and the impact of HIV in the era of highly active antiretroviral therapy: a meta-analysis
  publication-title: AIDS
  doi: 10.1097/QAD.0b013e32830e6d51
– volume: 15
  start-page: 165
  year: 2008
  ident: 10.1016/j.jhep.2012.06.010_b0155
  article-title: Liver cirrhosis in HIV-infected patients: prevalence, aetiology and clinical outcome
  publication-title: J Viral Hepat
  doi: 10.1111/j.1365-2893.2007.00903.x
– volume: 300
  start-page: 51
  year: 2008
  ident: 10.1016/j.jhep.2012.06.010_b0040
  article-title: Changes in the risk of death after HIV seroconversion compared with mortality in the general population
  publication-title: JAMA
  doi: 10.1001/jama.300.1.51
– volume: 19
  start-page: S13
  year: 2005
  ident: 10.1016/j.jhep.2012.06.010_b0130
  article-title: HIV, hepatitis C and HIV/hepatitis C virus co-infection in vulnerable populations
  publication-title: AIDS
  doi: 10.1097/01.aids.0000192065.09281.01
– volume: 49
  start-page: 1605
  year: 2009
  ident: 10.1016/j.jhep.2012.06.010_b0080
  article-title: Meta-analysis: increased mortality associated with hepatitis C in HIV-infected persons is unrelated to HIV disease progression
  publication-title: Clin Infect Dis
  doi: 10.1086/644771
– volume: 9
  start-page: 383
  year: 2005
  ident: 10.1016/j.jhep.2012.06.010_b0205
  article-title: Natural history of hepatitis C
  publication-title: Clin Liver Dis
  doi: 10.1016/j.cld.2005.05.003
SSID ssj0003094
Score 2.3916423
Snippet We aimed at comparing overall and liver-related mortality rates, observed in HIV positive subjects followed-up in the Cohorts of Spanish Network on HIV/AIDS...
Background & Aims We aimed at comparing overall and liver-related mortality rates, observed in HIV positive subjects followed-up in the Cohorts of Spanish...
SourceID proquest
pubmed
pascalfrancis
crossref
elsevier
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 743
SubjectTerms Acquired Immunodeficiency Syndrome - mortality
Adult
Biological and medical sciences
Cause of death
Coinfection - mortality
Female
Gastroenterology and Hepatology
Gastroenterology. Liver. Pancreas. Abdomen
HCV
Hepatitis C, Chronic - mortality
Heterosexuality - statistics & numerical data
HIV
HIV Seropositivity - mortality
Homosexuality, Male - statistics & numerical data
Human viral diseases
Humans
Infectious diseases
Liver Diseases - mortality
Liver Diseases - virology
Male
Medical sciences
Mortality
Spain - epidemiology
Standardized mortality ratio
Substance Abuse, Intravenous - mortality
Viral diseases
Viral diseases of the lymphoid tissue and the blood. Aids
Viral hepatitis
Title All-cause and liver-related mortality in HIV positive subjects compared to the general population: Differences by HCV co-infection
URI https://www.clinicalkey.com/#!/content/1-s2.0-S0168827812004369
https://www.clinicalkey.es/playcontent/1-s2.0-S0168827812004369
https://dx.doi.org/10.1016/j.jhep.2012.06.010
https://www.ncbi.nlm.nih.gov/pubmed/22709620
https://www.proquest.com/docview/1041143554
Volume 57
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3da9RAEF9KBRFE_DZVjxV8k-1lP5P4dpyWVG0RtaVvy2azW6-cuaO5E3zxwb_c2WRzpVgr-BQSdpLN7mTmt5vfzCD00nJb5JQ6YpXxRBTUE-O5IR4sH7O2qGoVgpMPDlV5JN6dyJMtNB1iYQKtMtr-3qZ31jpeGcfRHC9ns_FnACsADzPwUF0e9RDEJ0QWtHz35wXNg6dFzO-dk9A6Bs70HK-zry7krAz7gWo3DVG0Vzun20vTwpD5vtbF38Fo55T27qI7EU3iSd_he2jLNffRzYP4v_wB-jWZz4k169Zh09R4HkgYpAtfcTX-1iFvQOF41uBy_xj3BK7vDrfrKmzPtHhgqOPVAgNSxKd9kmpoOZT9eo3fxBIrYHBw9QOX02MQIwPJq3mIjvbefpmWJFZdIFZytSKF5XltQ559aT0AkKrytTCFksJ5pRwTdcVsYVVWp1JWPLXMW29czZyX4Pksf4S2m0XjniDsJUs9yxyzcAsOSzXKjHHeuZxaYUWeIDoMt7YxJXmojDHXA_fsTIcp0mGKdCDg0TRBrzYyyz4hx7Wt-TCLegg1BeOowV9cK5VdJeXa-H23muoWGus_dDBBciN5SY3_-cTRJRXbvBpTHJbcGU_Qi0HnNBiA8FfHNG6xhq6kggbQK0WCHvfKeCHNMliisnTnP7v1FN0KZz158RnaXp2v3XMAYatq1H1lI3RjMv304WM47r8vD38DyZ8zxw
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwED-NTgKkCfE1CB_DSLwh08SO88FbVZhStvaFbdqb5Tg2dCpptbRIvPKXc06cookxJF4TX-LYl7uf7d_dAbzRXOdZFBmqE2VpnEeWKssVtWj5mNZ5WSUuOHk6S4rT-NO5ON-BcR8L42iV3vZ3Nr211v7K0I_mcDWfDz8jWEF4mKKHavOo57dg12WnEgPYHU2OitnWIPMw9ym-M-oEfOxMR_O6-Gpc2kq3JZi8C10g7fX-aW-lGhw125W7-Dsebf3S4X245wElGXV9fgA7pn4It6f-yPwR_BwtFlSrTWOIqiuycDwM2kawmIp8a8E3AnEyr0kxOSMdh-u7Ic2mdDs0DelJ6mS9JAgWyZcuTzW27Ct_vScffJUVtDmk_EGK8RmK0Z7nVT-G08OPJ-OC-sILVAuerGmueVZpl2pfaIsYpCxtFas8EbGxSWJYXJVM5zpJq1CIkoeaWW2VqZixAp2f5vswqJe1eQrEChZalhqm8REcV2sRU8pYY7JIxzrOAoj64ZbaZyV3xTEWsqefXUg3RdJNkXQcvCgM4O1WZtXl5LixNe9nUfbRpmgfJbqMG6XS66RM43_xRkaywcbyDzUMQGwlr2jyP994cEXFtp_GEo6r7pQH8LrXOYk2wB3sqNosN9iVMI4c7hVxAE86ZfwtzVJcpbLw2X926xXcKU6mx_J4Mjt6DnfdnY7L-AIG68uNeYmYbF0e-H_uF5RLNOM
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=All-cause+and+liver-related+mortality+in+HIV+positive+subjects+compared+to+the+general+population%3A+differences+by+HCV+co-infection&rft.jtitle=Journal+of+hepatology&rft.au=Hernando%2C+Victoria&rft.au=Perez-Cachafeiro%2C+Santiago&rft.au=Lewden%2C+Charlotte&rft.au=Gonzalez%2C+Juan&rft.date=2012-10-01&rft.eissn=1600-0641&rft.volume=57&rft.issue=4&rft.spage=743&rft_id=info:doi/10.1016%2Fj.jhep.2012.06.010&rft_id=info%3Apmid%2F22709620&rft.externalDocID=22709620
thumbnail_m http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F01688278%2FS0168827812X00102%2Fcov150h.gif